Min‐Hui Chi
Impact in
- Pharmacology top 10%
- Drug-Induced Adverse Reactions
- Pharmacogenetics and Drug Metabolism
- Hepatology top 10%
- Hepatocellular Carcinoma Treatment and Prognosis
Papers in
-
- Hepatocellular Carcinoma Treatment and Prognosis 7
-
- Drug-Induced Adverse Reactions 6
- Pharmacogenetics and Drug Metabolism 1
- Co-authors
- Yongyi Zeng (5 shared papers)Jingyao Huang (1 shared paper)Chun‐Bing Chen (8 shared papers)Chuang‐Wei Wang (7 shared papers)Mao-Lin Yan (1 shared paper)Rosaline Chung‐Yee Hui (7 shared papers)Jiafei Chen (1 shared paper)Hao Lü (1 shared paper)
In The Last Decade
Min‐Hui Chi
19 papers receiving 253 citations
Peers
Comparison fields: 5 of 36
- Pharmacology 114
- Hepatology 63
- Dermatology 14
- Toxicology 6
- Pharmacology 10
Countries citing papers authored by Min‐Hui Chi
This map shows the geographic impact of Min‐Hui Chi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Min‐Hui Chi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Min‐Hui Chi more than expected).
Fields of papers citing papers by Min‐Hui Chi
This network shows the impact of papers produced by Min‐Hui Chi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Min‐Hui Chi. The network helps show where Min‐Hui Chi may publish in the future.
Co-authors
The 25 scholars most cited alongside Min‐Hui Chi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 65 | |
| 2 | 2023 | 49 | |
| 3 | 2020 | 29 | |
| 4 | 2020 | 20 | |
| 5 | 2015 | 18 | |
| 6 | 2012 | 13 | |
| 7 | 2022 | 12 | |
| 8 | 2023 | 11 | |
| 9 | 2022 | 10 | |
| 10 | 2023 | 7 | |
| 11 | 2022 | 6 | |
| 12 | 2024 | 5 | |
| 13 | 2024 | 4 | |
| 14 | 2019 | 2 | |
| 15 | 2024 | 2 | |
| 16 | 2025 | 2 | |
| 17 | [The effect of different hepatic vascular exclusion for massive hemorrhage in hepatectomy]. | 2010 | 1 |
| 18 | 2019 | 1 | |
| 19 | 2025 | 1 | |
| 20 | 2025 | 0 |
About Min‐Hui Chi
Min‐Hui Chi is a scholar working on Hepatology, Pharmacology, Urology, Dermatology and Pharmacology, having authored 20 papers that have together received 258 indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (7 papers), Drug-Induced Adverse Reactions (6 papers), Dermatology and Skin Diseases (1 paper), Electrochemical sensors and biosensors (1 paper), Pharmacogenetics and Drug Metabolism (1 paper), Autoimmune Bullous Skin Diseases (1 paper), Epigenetics and DNA Methylation (1 paper) and Advanced biosensing and bioanalysis techniques (1 paper). The work is most often cited by research in Pharmacology (114 citations), Hepatology (63 citations), Dermatology (14 citations), Toxicology (6 citations) and Pharmacology (10 citations). Min‐Hui Chi has collaborated with scholars based in China, Taiwan and Thailand. Frequent co-authors include Yongyi Zeng, Jingyao Huang, Chun‐Bing Chen, Chuang‐Wei Wang, Mao-Lin Yan, Rosaline Chung‐Yee Hui, Jiafei Chen, Hao Lü, Chun‐Wei Lu and Hui Zhang. Their work appears in journals such as British Journal of Dermatology, Clinical Pharmacology & Therapeutics, EClinicalMedicine, Combinatorial Chemistry & High Throughput Screening and Journal of Clinical Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.